ABCL
Price
$3.62
Change
-$0.12 (-3.21%)
Updated
Dec 12 closing price
Capitalization
1.08B
73 days until earnings call
Intraday BUY SELL Signals
CUE
Price
$0.49
Change
-$0.00 (-0.00%)
Updated
Dec 12 closing price
Capitalization
38.35M
101 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs CUE

Header iconABCL vs CUE Comparison
Open Charts ABCL vs CUEBanner chart's image
AbCellera Biologics
Price$3.62
Change-$0.12 (-3.21%)
Volume$2.65M
Capitalization1.08B
Cue Biopharma
Price$0.49
Change-$0.00 (-0.00%)
Volume$395.99K
Capitalization38.35M
ABCL vs CUE Comparison Chart in %
View a ticker or compare two or three
VS
ABCL vs. CUE commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and CUE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 14, 2025
Stock price -- (ABCL: $3.74 vs. CUE: $0.49)
Brand notoriety: ABCL and CUE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 54% vs. CUE: 133%
Market capitalization -- ABCL: $1.08B vs. CUE: $38.35M
ABCL [@Biotechnology] is valued at $1.08B. CUE’s [@Biotechnology] market capitalization is $38.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCUE’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CUE’s FA Score: 1 green, 4 red.
According to our system of comparison, CUE is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while CUE’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 4 bearish.
  • CUE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ABCL and CUE are a good buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а +2.47% price change this week, while CUE (@Biotechnology) price change was -10.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

ABCL is expected to report earnings on Feb 24, 2026.

CUE is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.08B) has a higher market cap than CUE($38.4M). ABCL YTD gains are higher at: 27.645 vs. CUE (-54.752). CUE has higher annual earnings (EBITDA): -35.19M vs. ABCL (-212.36M). ABCL has more cash in the bank: 496M vs. CUE (18.7M). CUE has less debt than ABCL: CUE (6.17M) vs ABCL (142M). ABCL has higher revenues than CUE: ABCL (35.3M) vs CUE (7.1M).
ABCLCUEABCL / CUE
Capitalization1.08B38.4M2,823%
EBITDA-212.36M-35.19M603%
Gain YTD27.645-54.752-50%
P/E RatioN/AN/A-
Revenue35.3M7.1M497%
Total Cash496M18.7M2,652%
Total Debt142M6.17M2,300%
FUNDAMENTALS RATINGS
CUE: Fundamental Ratings
CUE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLCUE
RSI
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 24 days ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
CUE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STMSX25.640.37
+1.46%
SEI Tax-Managed Small/Mid Cap F (SIMT)
HILFX34.090.27
+0.80%
Hennessy Large Cap Financial Instl
JNBCX10.500.02
+0.19%
JPMorgan Income Builder C
RINCX21.460.01
+0.05%
Victory RS Science and Technology C
JDERX10.69-1.50
-12.31%
PGIM Jennison Mid-Cap Growth R

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-0.80%
RXRX - ABCL
58%
Loosely correlated
-3.98%
CRSP - ABCL
57%
Loosely correlated
+0.87%
VCYT - ABCL
56%
Loosely correlated
-2.56%
ABSI - ABCL
55%
Loosely correlated
-3.27%
DNA - ABCL
52%
Loosely correlated
+1.23%
More

CUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CUE has been loosely correlated with SGMT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CUE jumps, then SGMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUE
1D Price
Change %
CUE100%
+3.33%
SGMT - CUE
43%
Loosely correlated
+0.16%
ABCL - CUE
40%
Loosely correlated
-0.80%
CRBU - CUE
39%
Loosely correlated
-2.11%
VCYT - CUE
36%
Loosely correlated
-2.56%
LTRN - CUE
35%
Loosely correlated
-2.09%
More